公司資料
Dynavax Technologies 股價、新聞與催化劑
已下市
- 股票代碼:
- DVAX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for DVAX.
公司概覽
業務概覽
Dynavax Technologies is a vaccine company best known for HEPLISAV-B and additional innate-immune platform work. The company combines commercial product execution with immunology-driven pipeline optionality.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Dynavax sits in specialty biopharma.
商業模式特徵
The business depends on vaccine sales, commercial traction, and the ability to expand beyond its core hepatitis-B franchise.
生技產業定位
Dynavax is a commercial specialty-pharma name with catalyst sensitivity around vaccines, partnerships, and pipeline progress.
未來催化劑
- Dynavax's catalysts are HEPLISAV-B execution and CpG 1018 adjuvant partnerships, which together support the vaccine-platform story. The company improves when the commercial base and partner flow both stay healthy.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。